Axsome Therapeutics (AXSM) PT Raised to $200 at Truist Securities

February 18, 2025 1:13 PM

Truist Securities analyst Joon Lee raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $200.00 (from $190.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found